Quick Takeaways
- Jay R. Venkatesan has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $37,396,284.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jay R. Venkatesan
- Location
- San Francisco, CA
- Summary
- The estimated net worth of Jay R. Venkatesan is at least $37,396,284 dollars as of 10 Nov 2025. Jay R. Venkatesan is the Director, 10%+ Owner of ALPINE IMMUNE SCIENCES, INC. and owns shares of ALPINE IMMUNE SCIENCES, INC. stock worth about $36.64M. Jay R. Venkatesan is the Director of Serina Therapeutics, Inc. and owns shares of Serina Therapeutics, Inc. (SER) stock worth about $500K. Jay R. Venkatesan is the Director of Elicio Therapeutics, Inc. and owns shares of Elicio Therapeutics, Inc. (ELTX) stock worth about $251.3K.
- Signature
- /s/ Jay R. Venkatesan
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jay R. Venkatesan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ALPINE IMMUNE SCIENCES, INC. ($36,644,978).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jay R. Venkatesan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | $36,644,978 | 15 Jul 2022 | ||
| SER | Serina Therapeutics, Inc. | Director | $500,000 | 07 Nov 2025 | ||
| ELTX | Elicio Therapeutics, Inc. | Director | $251,306 | 19 May 2025 |
Insider Transactions Reported by Jay R. Venkatesan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.